openPR Logo
Press release

Oral Drug Delivery Market Demands, Overview, Size, Share and Key Players - AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company

10-18-2022 02:21 PM CET | Health & Medicine

Press release from: ReportsnReports

Oral Drug Delivery Market

Oral Drug Delivery Market

Oral Drug Delivery Market is a proficient and comprehensive marketing report that focuses on primary and secondary market drivers, market share, leading segments, and geographical analysis. Nowadays, businesses get highly benefited from the different segments covered in the market research report which makes available better market insights to them with which they can drive the business in the right direction. This market report covers an array of aspects of the market analysis which today's businesses call for. The Oral Drug Delivery Market report is produced through the systematic gathering and analysis of information about individuals or organizations which is conducted through social and opinion research.

Request a Free PDF Sample of the Report: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5789611

Oral Drug Delivery market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Oral Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Oral Drug Delivery market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
- Diffusion Controlled Release System
- Dissolution Controlled Release System
- Ion Exchange Resins Controlled Release
- Hydro-dynamically Balanced Drug Delivery System
- Osmotically Controlled Release System
- Dissolution & Diffusion Controlled Release System

Segment by Application
- Hospitals
- Clinics
- Other

By Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

By Company
- AstraZeneca Plc.
- Mylan N.V.
- Sanofi
- F. Hoffman-La-Roche Ltd.
- Bristol-Myers Squibb Company
- Sun Pharmaceuticals Industries Ltd
- Abbott Laboratories
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Vectura Group plc.
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc

Purchase This Report: https://www.reportsnreports.com/purchase.aspx?name=5789611

Table of Contents

1 Study Coverage
1.1 Oral Drug Delivery Product Introduction
1.2 Global Oral Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oral Drug Delivery Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oral Drug Delivery Sales in Volume for the Year 2017-2028
1.3 United States Oral Drug Delivery Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oral Drug Delivery Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oral Drug Delivery Sales in Volume for the Year 2017-2028
1.4 Oral Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oral Drug Delivery in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oral Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oral Drug Delivery Market Dynamics
1.5.1 Oral Drug Delivery Industry Trends
1.5.2 Oral Drug Delivery Market Drivers
1.5.3 Oral Drug Delivery Market Challenges
1.5.4 Oral Drug Delivery Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oral Drug Delivery Market Segment by Type
2.1.1 Diffusion Controlled Release System
2.1.2 Dissolution Controlled Release System
2.1.3 Ion Exchange Resins Controlled Release
2.1.4 Hydro-dynamically Balanced Drug Delivery System
2.1.5 Osmotically Controlled Release System
2.1.6 Dissolution & Diffusion Controlled Release System
2.2 Global Oral Drug Delivery Market Size by Type
2.2.1 Global Oral Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oral Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oral Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oral Drug Delivery Market Size by Type
2.3.1 United States Oral Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oral Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oral Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oral Drug Delivery Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Oral Drug Delivery Market Size by Application
3.2.1 Global Oral Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oral Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oral Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oral Drug Delivery Market Size by Application
3.3.1 United States Oral Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oral Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oral Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oral Drug Delivery Competitor Landscape by Company
4.1 Global Oral Drug Delivery Market Size by Company
4.1.1 Top Global Oral Drug Delivery Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oral Drug Delivery Revenue by Manufacturer (2017-2022)
4.1.3 Global Oral Drug Delivery Sales by Manufacturer (2017-2022)
4.1.4 Global Oral Drug Delivery Price by Manufacturer (2017-2022)
4.2 Global Oral Drug Delivery Concentration Ratio (CR)
4.2.1 Oral Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Drug Delivery in 2021
4.2.3 Global Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oral Drug Delivery Manufacturing Base Distribution, Product Type
4.3.1 Global Oral Drug Delivery Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oral Drug Delivery Product Type
4.3.3 Date of International Manufacturers Enter into Oral Drug Delivery Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oral Drug Delivery Market Size by Company
4.5.1 Top Oral Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oral Drug Delivery Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oral Drug Delivery Sales by Players (2020, 2021 & 2022)
5 Global Oral Drug Delivery Market Size by Region
5.1 Global Oral Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oral Drug Delivery Market Size in Volume by Region (2017-2028)
5.2.1 Global Oral Drug Delivery Sales in Volume by Region: 2017-2022
5.2.2 Global Oral Drug Delivery Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oral Drug Delivery Market Size in Value by Region (2017-2028)
5.3.1 Global Oral Drug Delivery Sales in Value by Region: 2017-2022
5.3.2 Global Oral Drug Delivery Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oral Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Oral Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oral Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oral Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oral Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Oral Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oral Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Oral Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oral Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oral Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 AstraZeneca Plc.
7.1.1 AstraZeneca Plc. Corporation Information
7.1.2 AstraZeneca Plc. Description and Business Overview
7.1.3 AstraZeneca Plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AstraZeneca Plc. Oral Drug Delivery Products Offered
7.1.5 AstraZeneca Plc. Recent Development
7.2 Mylan N.V.
7.2.1 Mylan N.V. Corporation Information
7.2.2 Mylan N.V. Description and Business Overview
7.2.3 Mylan N.V. Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Mylan N.V. Oral Drug Delivery Products Offered
7.2.5 Mylan N.V. Recent Development
7.3 Sanofi
7.3.1 Sanofi Corporation Information
7.3.2 Sanofi Description and Business Overview
7.3.3 Sanofi Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Sanofi Oral Drug Delivery Products Offered
7.3.5 Sanofi Recent Development
7.4 F. Hoffman-La-Roche Ltd.
7.4.1 F. Hoffman-La-Roche Ltd. Corporation Information
7.4.2 F. Hoffman-La-Roche Ltd. Description and Business Overview
7.4.3 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.4.4 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Products Offered
7.4.5 F. Hoffman-La-Roche Ltd. Recent Development
7.5 Bristol-Myers Squibb Company
7.5.1 Bristol-Myers Squibb Company Corporation Information
7.5.2 Bristol-Myers Squibb Company Description and Business Overview
7.5.3 Bristol-Myers Squibb Company Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bristol-Myers Squibb Company Oral Drug Delivery Products Offered
7.5.5 Bristol-Myers Squibb Company Recent Development
7.6 Sun Pharmaceuticals Industries Ltd
7.6.1 Sun Pharmaceuticals Industries Ltd Corporation Information
7.6.2 Sun Pharmaceuticals Industries Ltd Description and Business Overview
7.6.3 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Products Offered
7.6.5 Sun Pharmaceuticals Industries Ltd Recent Development
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporation Information
7.7.2 Abbott Laboratories Description and Business Overview
7.7.3 Abbott Laboratories Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Abbott Laboratories Oral Drug Delivery Products Offered
7.7.5 Abbott Laboratories Recent Development
7.8 Merck & Co. Inc.
7.8.1 Merck & Co. Inc. Corporation Information
7.8.2 Merck & Co. Inc. Description and Business Overview
7.8.3 Merck & Co. Inc. Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Merck & Co. Inc. Oral Drug Delivery Products Offered
7.8.5 Merck & Co. Inc. Recent Development
7.9 Novartis AG
7.9.1 Novartis AG Corporation Information
7.9.2 Novartis AG Description and Business Overview
7.9.3 Novartis AG Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Novartis AG Oral Drug Delivery Products Offered
7.9.5 Novartis AG Recent Development
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Corporation Information
7.10.2 Pfizer Inc. Description and Business Overview
7.10.3 Pfizer Inc. Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Pfizer Inc. Oral Drug Delivery Products Offered
7.10.5 Pfizer Inc. Recent Development
7.11 Vectura Group plc.
7.11.1 Vectura Group plc. Corporation Information
7.11.2 Vectura Group plc. Description and Business Overview
7.11.3 Vectura Group plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Vectura Group plc. Oral Drug Delivery Products Offered
7.11.5 Vectura Group plc. Recent Development
7.12 GlaxoSmithKline plc.
7.12.1 GlaxoSmithKline plc. Corporation Information
7.12.2 GlaxoSmithKline plc. Description and Business Overview
7.12.3 GlaxoSmithKline plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.12.4 GlaxoSmithKline plc. Products Offered
7.12.5 GlaxoSmithKline plc. Recent Development
7.13 Johnson & Johnson Services, Inc
7.13.1 Johnson & Johnson Services, Inc Corporation Information
7.13.2 Johnson & Johnson Services, Inc Description and Business Overview
7.13.3 Johnson & Johnson Services, Inc Oral Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Johnson & Johnson Services, Inc Products Offered
7.13.5 Johnson & Johnson Services, Inc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oral Drug Delivery Industry Chain Analysis
8.2 Oral Drug Delivery Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oral Drug Delivery Distributors
8.3 Oral Drug Delivery Production Mode & Process
8.4 Oral Drug Delivery Sales and Marketing
8.4.1 Oral Drug Delivery Sales Channels
8.4.2 Oral Drug Delivery Distributors
8.5 Oral Drug Delivery Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oral Drug Delivery Market Demands, Overview, Size, Share and Key Players - AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company here

News-ID: 2771357 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase